Taus-García Alvaro, Sánchez-Font Albert, Servitja-Tormo Sònia, Pijuan Lara, Maiques-Llácer José María, Curull Víctor
Servei d'Oncologia Mèdica, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Universitat Pompeu Fabra, Barcelona, España.
Arch Bronconeumol. 2010 Aug;46(8):442-4. doi: 10.1016/j.arbres.2009.09.016. Epub 2009 Nov 13.
Organizing pneumonia is a clinical and histological condition in which the onset is usually subacute with respiratory symptoms and pulmonary infiltrates. It may be unknown origin (cryptogenic) or associated with other illnesses, infectious diseases or drugs. We present a 60 year-old female patient with a previous history of breast cancer, who was being treated with trastuzumab, an antiHER2 monoclonal antibody. She was diagnosed with casual pulmonary infiltrates that had histological changes compatible with organizing pneumonia. The pulmonary infiltrates disappeared on withdrawing trastuzumab treatment. Due to the increasing use of biological therapies in different medical areas, we believe it is of interest to report this pulmonary involvement attributed to the monoclonal antibody trastuzumab.
机化性肺炎是一种临床和组织学状况,其起病通常为亚急性,伴有呼吸道症状和肺部浸润。它可能病因不明(隐源性),或与其他疾病、传染病或药物有关。我们报告一名60岁女性患者,既往有乳腺癌病史,正在接受抗HER2单克隆抗体曲妥珠单抗治疗。她被诊断为偶然发现的肺部浸润,组织学改变符合机化性肺炎。停用曲妥珠单抗治疗后,肺部浸润消失。由于生物疗法在不同医学领域的使用日益增加,我们认为报告这种由单克隆抗体曲妥珠单抗引起的肺部病变很有意义。